Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans

American Journal of Hypertension

Volumn 16, Issue 5 I, 2003, Pages 331-336

  Lopes, Heno F ^a,b   Morrow, Jason D ^c   Stoijiljkovic, Milos P ^a,d   Goodfriend, Theodore L ^e   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF DEFENCE   (Serbia)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

African Americans; F2 isoprostanes; Heparin; Intralipid; Oxidative stress

Indexed keywords

FATTY ACID; HEPARIN; INTRALIPID; ISOPROSTANE; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNOLOGY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0038065602     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00041-4     Document Type: Article

References (36)

1. Saunders E: Hypertension in blacks. Med Clin North Am 1987;71:1013-1029.
2. Weinick RM, Zuvekas SH, Cohen JW: Racial and ethnic differences in access to and use of health care services, 1977 to 1996. Med Care Res Rev 2000;57:36-54.
3. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP: The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
4. Karanja NM, McCullough ML, Kumanyika SK, Pedulal KL, Windhauser MM, Obarzanek E, Lin PH, Champagne CM, Swain F: Pre-enrollment diets of Dietary Approaches to Stop Hypertension trial participants. DASH Collaborative Research Group. J Am Diet Assoc 1999;99(Suppl):S28-S34.
5. Wheeler FC, Lackland DT, Mace ML, Reddick A, Hogelin G, Remington PL: Evaluating South Carolina's community cardiovascular disease prevention project. Public Health Rep 1991;106:536-543.
6. Facchini FS, Hua NW, Reaven GM, Stoohs RA: Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med 2000;29:1302-1306.
7. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens 2000:18:655-673.
8. Laursen JB RS, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997;95:557-559.
9. Vaziri ND, Wang XQ, Oveisi F, Rad B: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
10. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Duagherty SA, Weinberger MH: Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 1991;17:I102-I108.
11. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW: Oxidative stress in the Dahl hypertensive rat. Hypertension 1997;30:1628-1633.
12. Laakso J, Mervaala E, Himberg JJ, Teravainen TL, Karppanen H, Vapaatalo H, Lapatto R: Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension 1998;32:902-906.
13. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK: p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317-23321.
14. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-2579.
15. Haugen E, Nath KA: The involvement of oxidative stress in the progression of renal injury. Blood Purif 1999;17:58-65.
16. Egan BM, Greene EL, Goodfriend TL: Insulin resistance and cardiovascular disease. Am J Hypertens 2001;14(Suppl):116S-125S.
17. Stojiljkovic MP, Lopes HF, Zhang D, Morrow JD, Goodfriend TL, Egan BM: Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002;20:1215-1221.
18. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM: DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003;41:422-430.
19. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN: Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 1999;33:1392-1398.
20. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM: Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol 2001;280:R1674-R1679.
21. Awad JA, Morrow JD, Takahashi K Roberts LJ 2nd: Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem 1993;268:4161-4169.
22. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 1993;34:1021-1028.
23. Roberts LJ, Morrow JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513.
24. Matthews DR, Hosker JP. Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
25. Neuhouser ML, Rock CL, Eldridge AL, Kristal AR, Patterson RE, Cooper DA, Neumark-Sztainer D, Cheskin LJ, Thornquist MD: Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr 2001;131:2184-2191.
26. Patterson BH, Harlan LC, Block G, Kahle L: Food choices of whites, blacks, and Hispanics: data from the 1987 National Health Interview Survey. Nutr Cancer 1995;23:105-119.
27. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy B: Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999;159:285-293.
28. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH: Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
29. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA. Pratt JH: Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-1082.
30. Schuster DP, Kien CL, Osei K: Differential impact of obesity on glucose metabolism in black and white American adolescents. Am J Med Sci 1998;316:361-367.
31. Gower BA, Nagy TR, Goran MI: Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 1999;48:1515-1521.
32. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
33. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-766.
34. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-1024.
35. Castro Cabezas M, de Bruin TW, de Valk HW, Shoulders CC, Jansen H, Willem Erkelens D: Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 1993;92:160-168.
36. Tyroler HA, Glueck CJ, Christensen B Kwiterovich PO Jr: Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation 1980;62(4 Pt 2):IV99-IV107.